Matthew Boyton

Mendelian randomisation identifies proteins with effects on multiple sclerosis and related traits

Background Multiple sclerosis (MS) is a chronic inflammatory and neurodegenerative disease with limited treatment options and frequent co-occurring conditions that complicate management. Genetic approaches can be applied to identify causal proteins and prioritise potential therapeutic targets across the landscape of MS...